Multimodal vs Symptom-Specific Treatments for Concussion
(SMART Trial)
Trial Summary
What is the purpose of this trial?
Given the rising rates of concussion in youth ages 10-19 and the significant proportion of young people who remain symptomatic for months following concussion, research evaluating the efficacy of multifaceted treatment options following concussion is imperative. Studies examining the efficacy of treatment strategies following concussion in children and adults are surprisingly limited, and most focus on one treatment approach, have small sample sizes, are not randomized controlled trials, and focus on individuals with prolonged recovery (months). There is a need for a multifaceted treatment trial to examine the early implementation of treatment approaches that may reduce prolonged recovery while considering the heterogeneous presentation of symptoms and patient preferences in the sub-acute stage following concussion. Randomized controlled trials that consider a multifaceted transdisciplinary approach to treatment in the early period following concussion are needed to raise the bar regarding evidence-informed management following concussion
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment for concussion?
Research suggests that a multimodal approach, including physical therapy and neck treatment, can help manage symptoms like headache, dizziness, and neck pain in people with persistent post-concussion symptoms. Studies indicate that these treatments can improve or sustain symptom relief over time, although some symptoms may recur.12345
Is the multimodal or symptom-specific treatment for concussion safe for humans?
Research indicates that treatments involving physical therapy and multidisciplinary care for concussion, including neck treatment and symptom-specific approaches, are generally safe. Participants in studies reported improvements in symptoms like headache, dizziness, and neck pain, although some experienced recurrent symptoms over time.12367
How is the Multimodal vs Symptom-Specific Treatments for Concussion unique compared to other treatments?
This treatment is unique because it combines multiple approaches, such as physical therapy, vestibular rehabilitation, and symptom-specific treatments for dizziness, neck pain, headaches, and sleep disturbances, to address the diverse symptoms of post-concussion syndrome. This comprehensive, multidisciplinary approach aims to improve recovery by targeting the specific needs of each patient, unlike standard treatments that may focus on only one aspect of the condition.12358
Research Team
Carolyn Emery, PhD
Principal Investigator
University of Calgary
Eligibility Criteria
The SMART Concussion Trial is for young people aged 13-19 who've had a concussion with symptoms like headaches, dizziness, or neck pain lasting over a week but less than three weeks. They must be able to communicate in English and have access to a smartphone or computer. Those with severe brain injuries, certain medical conditions, or an inability to participate in physical activities due to reasons other than the concussion cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive symptom-specific or multimodal treatment for up to 6 weeks, including headache treatment, dizziness/neck pain treatment, or a combination of physiotherapy and cognitive-behavioral interventions.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of symptom changes and quality of life.
Long-term Follow-up
Participants are monitored for return to unrestricted physical activity and long-term outcomes.
Treatment Details
Interventions
- Generic Concussion Treatment (Behavioral Intervention)
- Symptom-specific Dizziness &/or Neck Pain Treatment (Other)
- Symptom-specific Headache Treatment (Procedure)
- Symptom-specific Sleep Disturbance Treatment (Behavioral Intervention)
Generic Concussion Treatment is already approved in Canada for the following indications:
- Symptomatic relief for post-concussion syndrome
- Rehabilitation for concussion-related injuries
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Dr. Shweta Patel
University of Calgary
Chief Medical Officer since 2020
MD from the University of Baroda Medical College, India
Dr. Edward McCauley
University of Calgary
President and Vice-Chancellor since 2018
PhD in Ecology and Evolutionary Biology from the University of California, Santa Barbara
Canadian Institutes of Health Research (CIHR)
Collaborator
Dr. Paul C. Hébert
Canadian Institutes of Health Research (CIHR)
Chief Executive Officer
MD, University of Ottawa
Dr. Paul C. Hébert
Canadian Institutes of Health Research (CIHR)
Chief Medical Officer
MD, University of Ottawa